GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $480,000 | -38.1% | 8,700 | -29.3% | 0.02% | -44.8% |
| Q2 2020 | $776,000 | +207.9% | 12,300 | +149.4% | 0.03% | +163.6% |
| Q1 2020 | $252,000 | -29.6% | 4,932 | +9.6% | 0.01% | -8.3% |
| Q4 2019 | $358,000 | +72.1% | 4,500 | +13.9% | 0.01% | +71.4% |
| Q1 2019 | $208,000 | -1.4% | 3,950 | -23.3% | 0.01% | -12.5% |
| Q4 2018 | $211,000 | -43.1% | 5,150 | -47.2% | 0.01% | -38.5% |
| Q3 2018 | $371,000 | +3.3% | 9,750 | +22.6% | 0.01% | -7.1% |
| Q2 2018 | $359,000 | +13.2% | 7,950 | +21.4% | 0.01% | +16.7% |
| Q1 2018 | $317,000 | +10.1% | 6,550 | -10.6% | 0.01% | +9.1% |
| Q4 2017 | $288,000 | – | 7,325 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |